NDC 55111-762

Valganciclovir

Valganciclovir

Valganciclovir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is Valganciclovir Hydrochloride.

Product ID55111-762_01a187d9-f0b8-d068-0be0-98654e8de135
NDC55111-762
Product TypeHuman Prescription Drug
Proprietary NameValganciclovir
Generic NameValganciclovir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-12-15
Marketing CategoryANDA / ANDA
Application NumberANDA203511
Labeler NameDr. Reddy's Laboratories Limited
Substance NameVALGANCICLOVIR HYDROCHLORIDE
Active Ingredient Strength450 mg/1
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55111-762-05

500 TABLET, FILM COATED in 1 BOTTLE (55111-762-05)
Marketing Start Date2014-12-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55111-762-60 [55111076260]

Valganciclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203511
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-12-15

NDC 55111-762-78 [55111076278]

Valganciclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-15

NDC 55111-762-79 [55111076279]

Valganciclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-15

NDC 55111-762-05 [55111076205]

Valganciclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203511
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-15

Drug Details

Active Ingredients

IngredientStrength
VALGANCICLOVIR HYDROCHLORIDE450 mg/1

OpenFDA Data

SPL SET ID:f37c0780-b953-46c2-d7d4-959fc2c3e571
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313566

    • Pharmacological Class

    • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • DNA Polymerase Inhibitors [MoA]
    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]
    • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • DNA Polymerase Inhibitors [MoA]
    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    Medicade Reported Pricing

    55111076260 VALGANCICLOVIR 450 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Valganciclovir" or generic name "Valganciclovir"

    NDCBrand NameGeneric Name
    0603-6330ValganciclovirValganciclovir hydrochloride
    0904-6796ValganciclovirValganciclovir
    16714-765ValganciclovirValganciclovir
    27241-158ValganciclovirValganciclovir
    31722-832ValganciclovirValganciclovir
    31722-837VALGANCICLOVIRVALGANCICLOVIR HYDROCHLORIDE
    42291-875ValganciclovirValganciclovir hydrochloride
    48433-124ValganciclovirValganciclovir
    50268-787ValganciclovirValganciclovir
    55111-762ValganciclovirValganciclovir
    59651-444ValganciclovirValganciclovir hydrochloride powder,
    60429-846ValganciclovirValganciclovir
    63629-2288ValganciclovirValganciclovir hydrochloride
    63739-076ValganciclovirValganciclovir
    64380-153ValganciclovirValganciclovir hydrochloride
    68084-965ValganciclovirValganciclovir
    69097-277ValganciclovirValganciclovir
    0004-0038Valcytevalganciclovir
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.